Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesFixed-dose combinations of renin-angiotensin blocking agents with calcium channel blockers or hydrochlorothiazide in the treatment of hypertension
Expert Opinion in Pharmacotherapy, 06/22/09
Bramlage P - The evidence indicates that angiotensin converting enzyme inhibitor (ACEi)/CCB combinations are more effective in selected high-risk patients with compelling indications for the use of CCBs than are ACEi/HCTZ combinations. Side effects offset these data, and compelling indications may have favored the outcomes. Comparisons in a more unselected patient population are needed to define the role of particular drug–drug combinations.
Today in Cardiac/Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Fyi from human genome sciences: gsk initiates second pivotal phase 3 trial for investigational cardiovascular medication darapladib
Human Genome Sciences, 12/10/09
Reduction of blood pressure in patients with treatment-resistant hypertension
Expert Opinion in Pharmacotherapy, 12/09/09
Non-adherence to statin therapy: a major challenge for preventive cardiology
Expert Opinion in Pharmacotherapy, 12/08/09
Today in Dosing...keeping you current
Receive free subspecialty "5-minute updates" via email
Congenital abnormalities in children of 43 pregnant women who attempted suicide with large doses of nitrazepam
Pharmacoepidemiology and Drug Safety, 12/09/09
Pharmacokinetics and pharmacodynamics of LC15-0444, a novel dipeptidyl peptidase IV inhibitor, after multiple dosing in healthy volunteers
British Journal of Clinical Pharmacology, 12/09/09
Allos Therapeutics' FOLOTYN Shows Activity in a Dose Finding Phase 1 Study of Relapsed or Refractory Cutaneous T-Cell Lymphoma
Allos Therapeutics, 12/09/09
Today in Drug Interactions...keeping you current
Receive free subspecialty "5-minute updates" via email
A comparison of the acid-inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism
Alimentary Pharmacology and Therapeutics, 12/09/09
Combination of intensive cognitive rehabilitation and donepezil therapy in Alzheimer's disease (AD)
Archives of Gerontology and Geriatrics, 12/09/09
Subcutaneous Sumatriptan Pharmacokinetics: Delimiting the Monoamine Oxidase Inhibitor Effect
Headache: The Journal of Head and Face Pain, 12/08/09
Sponsor
Article Search
Sponsor